MANUFACTURERS LIFE INSURANCE COMPANY, THE - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 30.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$2,0000.0%7680.0%0.00%
Q1 2018$2,000
-33.3%
7680.0%0.00%
Q4 2017$3,000
-75.0%
768
-72.2%
0.00%
Q3 2017$12,000
+200.0%
2,762
+117.1%
0.00%
Q2 2017$4,000
-97.7%
1,272
-93.3%
0.00%
Q1 2017$175,000
+31.6%
19,050
+10.0%
0.00%
Q4 2016$133,000
-14.7%
17,321
+26.9%
0.00%
Q3 2016$156,000
-7.1%
13,6490.0%0.00%
Q2 2016$168,000
+40.0%
13,649
+9.8%
0.00%
Q1 2016$120,000
-56.0%
12,433
+2.8%
0.00%
Q4 2015$273,000
+39.3%
12,098
+2.4%
0.00%
Q3 2015$196,000
-24.9%
11,809
+2.0%
0.00%
Q2 2015$261,000
+11.5%
11,582
+27.4%
0.00%
Q1 2015$234,000
+22.5%
9,092
+3.4%
0.00%
Q4 2014$191,000
+13.0%
8,789
-1.6%
0.00%
Q3 2014$169,000
-17.6%
8,933
+1.4%
0.00%
Q2 2014$205,000
+41.4%
8,813
+104.5%
0.00%
Q1 2014$145,000
+2800.0%
4,309
+2334.5%
0.00%
Q4 2013$5,000
+66.7%
1770.0%0.00%
Q3 2013$3,0001770.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 4,042,989$8,571,0000.75%
NEXTHERA CAPITAL LP 634,715$1,346,0000.26%
Endurant Capital Management LP 219,114$465,0000.21%
Birchview Capital, LP 118,689$252,0000.16%
Perceptive Advisors 2,620,897$5,556,0000.15%
Alambic Investment Management, L.P. 53,972$114,0000.09%
Sofinnova Investments, Inc. 395,744$839,0000.08%
Kazazian Asset Management, LLC 31,475$67,0000.06%
Broadfin Capital, LLC 200,000$424,0000.06%
ESSEX INVESTMENT MANAGEMENT CO LLC 96,639$205,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders